Nishizaki T - Search Results

1

Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma.

Tabata C, Kanemura S, Tabata R, Masachika E, Shibata E, Otsuki T, Nishizaki T, Nakano T. Tabata C, et al. Among authors: nishizaki t. J Clin Gastroenterol. 2013 Sep;47(8):684-8. doi: 10.1097/MCG.0b013e318297fa65. J Clin Gastroenterol. 2013. PMID: 23685846

2

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma.

Tabata C, Shibata E, Tabata R, Kanemura S, Mikami K, Nogi Y, Masachika E, Nishizaki T, Nakano T. Tabata C, et al. Among authors: nishizaki t. BMC Cancer. 2013 Apr 24;13:205. doi: 10.1186/1471-2407-13-205. BMC Cancer. 2013. PMID: 23617783 Free PMC article.

3

Clinical significance of serum angiopoietin-1 in malignant peritoneal mesothelioma.

Mikami K, Tabata C, Tabata R, Nogi Y, Terada T, Honda M, Kamiya H, Nishizaki T, Nakano T. Mikami K, et al. Among authors: nishizaki t. Cancer Invest. 2013 Oct;31(8):511-5. doi: 10.3109/07357907.2013.830734. Epub 2013 Sep 6. Cancer Invest. 2013. PMID: 24010773

4

Urinary trypsin inhibitor suppresses migration of malignant mesothelioma.

Yaguchi T, Muramoto M, Nakano T, Nishizaki T. Yaguchi T, et al. Among authors: nishizaki t. Cancer Lett. 2010 Feb 28;288(2):214-8. doi: 10.1016/j.canlet.2009.07.003. Epub 2009 Aug 5. Cancer Lett. 2010. PMID: 19660858

5

Gene therapy using adenovirus against malignant mesothelioma.

Gotoh A, Kanno T, Nagaya H, Nakano T, Tabata C, Fukuoka K, Tagawa M, Nishizaki T. Gotoh A, et al. Among authors: nishizaki t. Anticancer Res. 2012 Sep;32(9):3743-7. Anticancer Res. 2012. PMID: 22993314

6

Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.

Masachika E, Kanno T, Nakano T, Gotoh A, Nishizaki T. Masachika E, et al. Among authors: nishizaki t. Anticancer Res. 2013 Mar;33(3):887-94. Anticancer Res. 2013. PMID: 23482758

7

Dipalmitoleoyl-phosphatidylethanolamine induces apoptosis of NCI-H28 malignant mesothelioma cells.

Kaku Y, Tsuchiya A, Kanno T, Nakano T, Nishizaki T. Kaku Y, et al. Among authors: nishizaki t. Anticancer Res. 2014 Apr;34(4):1759-64. Anticancer Res. 2014. PMID: 24692707

8

Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.

Kaku Y, Nagaya H, Tsuchiya A, Kanno T, Gotoh A, Tanaka A, Shimizu T, Nakao S, Tabata C, Nakano T, Nishizaki T. Kaku Y, et al. Among authors: nishizaki t. Cancer Sci. 2014 Jul;105(7):883-9. doi: 10.1111/cas.12429. Epub 2014 May 21. Cancer Sci. 2014. PMID: 24754309 Free PMC article.

9

Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma.

Nakajima Y, Kanno T, Nagaya T, Kuribayashi K, Nakano T, Gotoh A, Nishizaki T. Nakajima Y, et al. Among authors: nishizaki t. Cell Physiol Biochem. 2015;35(1):51-60. doi: 10.1159/000369674. Epub 2015 Jan 2. Cell Physiol Biochem. 2015. PMID: 25547995 Free article.

10

Diarachidonoylphosphoethanolamine induces necrosis/necroptosis of malignant pleural mesothelioma cells.

Kaku Y, Tsuchiya A, Kanno T, Nakano T, Nishizaki T. Kaku Y, et al. Among authors: nishizaki t. Cell Signal. 2015 Sep;27(9):1713-9. doi: 10.1016/j.cellsig.2015.05.007. Epub 2015 May 22. Cell Signal. 2015. PMID: 26004138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

512 results

Search Page

Filters